Altamonte Springs, FL (PRWEB) August 19, 2016
BioPlus Specialty Pharmacy (BioPlus), a leading innovative specialty pharmacy, is one of the specialty pharmacies granted access to the limited distribution medication Zinbryta™ (daclizumab) from Biogen and AbbVie. Zinbryta received approval from the U.S. Food and Drug Administration (FDA) for the treatment of the relapsing form of multiple sclerosis in adults.
“Zinbryta offers multiple sclerosis patients a new therapeutic choice to assist in the management of their condition and we are proud of being not only the first specialty pharmacy in the country to receive a Zinbryta referral but also the first in the country to send out a Zinbryta prescription to a patient,” shares Sharon Ferrer, VP of Pharmaceutical Relations at BioPlus. “Our specialty pharmacy’s extensive experience with autoimmune conditions, including multiple sclerosis, makes us a perfect partner for supporting patients prescribed this new medication. In addition, our ‘2-Hour Patient Acceptance Guarantee’ program ensures prompt treatment starts,” adds Ferrer.
Zinbryta is a humanized monoclonal antibody that binds selectively to interleukin-2 receptor subunits (CD25). It is provided as a long-acting injection medication that prescribed patients can self-administer subcutaneously once a month. Zinbryta gained FDA approval following two clinical trials showing greater benefit from Zinbryta in preventing multiple sclerosis relapses compared to an existing medication (Avonex), as well as in comparison to a placebo. Zinbryta is available as a limited distribution drug since it presents serious safety risks of liver injury and immune conditions. It is only prescribed to patients who have not responded to two or more other multiple sclerosis medications.
Multiple sclerosis is an inflammatory autoimmune disease affecting the central nervous system. In the relapsing form of multiple sclerosis, there are periods of more disease activity followed by times of remission. Over time, the remissions often become incomplete, leading to progressive decline in function and increased disability.
About BioPlus Specialty Pharmacy
BioPlus Specialty Pharmacy is the first specialty pharmacy to introduce a two-hour turnaround from referral to patient acceptance. BioPlus... Where healing begins in 2 hours. Our company celebrates 27 years of innovative excellence in specialty pharmacy, working closely with payers and the pharmaceutical industry, as well as with prescribers to get prompt treatment for patients, and directly supporting our patients nationwide to achieve optimal health outcomes. Our proprietary web tool Tap App connects prescribers to the pharmacy by bringing the pharmacy chart into the doctor’s office with real-time specialty pharmacy information and treatment monitoring.
BioPlus provides a complete range of specialty services, including for hepatitis C, multiple sclerosis, cancer, bleeding disorders, and other complex, chronic conditions. BioPlus, a privately-held, pharmacist-owned company based in Altamonte Springs, Florida, is accredited by URAC, VIPPS, and the Accreditation Commission for Health Care (ACHC).
For information: http://www.bioplusrx.com or